Results 171 to 180 of about 8,571 (202)
Some of the next articles are maybe not open access.

Properties of acid ceramidase from human spleen

Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1989
We have characterised ceramidase activity in extracts of human spleen from control subjects and from patients with Gaucher disease. In Triton X-100 extracts of control spleens, a broad pH optimum of pH 3.5-5.0 was found; no ceramidase activity was detectable at neutral or alkaline pH.
B J, Al   +5 more
openaire   +2 more sources

Development of an acid ceramidase activity-based probe

Chemical Communications, 2015
Acid ceramidase is responsible for the ultimate step in the catabolism of (glyco)sphingolipids by hydrolysis of ceramide into sphingosine and free fatty acid.
Ouairy, C.M.J.   +9 more
openaire   +3 more sources

Acid Ceramidase: A Novel Therapeutic Target in Cancer

Current Topics in Medicinal Chemistry, 2019
Sphingolipids are important constituents of the eukaryotic cell membrane which govern various signaling pathways related to different aspects of cell survival. Ceramide and Sphingosine are interconvertible sphingolipid metabolites, out of which Ceramide is pro-apoptotic and sphingosine is anti-apoptotic in nature.
Yadu, Vijayan   +2 more
openaire   +2 more sources

Human Acid Ceramidase Gene: Novel Mutations in Farber Disease

Molecular Genetics and Metabolism, 2000
Farber disease is an autosomal recessive disorder caused by lysosomal acid ceramidase (AC) deficiency. It commonly manifests during the first few months after birth with a unique triad of painful and progressive deformed joints, subcutaneous nodules, and progressive hoarseness. In order to understand the molecular mechanism(s) of pathogenesis of Farber
Z, Zhang   +7 more
openaire   +2 more sources

Acid ceramidase inhibition: a novel target for cancer therapy

Frontiers in Bioscience, 2008
During the last decade, sphingolipid deregulation, namely the balance between the pro-apoptotic molecule ceramide and the anti-apoptotic sphingolipid sphingosine-1-phosphate, has emerged as an important factor in cancer pathology and resistance to therapy.
Liu, X   +16 more
openaire   +3 more sources

Kinetic Characteristics of Acidic and Alkaline Ceramidase in Human Epidermis

Skin Pharmacology and Physiology, 2007
It has recently become evident that at least five ceramidase (CDase) isoforms are present in human epidermis, and that specifically acidic CDase (aCDase) and alkaline CDase (alkCDase) activities increase during keratinocyte differentiation, and thus might play a pivotal role(s) in permeability barrier function.
Houben, E.   +6 more
openaire   +4 more sources

Targeting IDH1-Mutated Oligodendroglioma with Acid Ceramidase Inhibitors

AbstractOligodendroglioma is genetically defined as a tumor harboring isocitrate dehydrogenase 1 or 2 mutations (IDH1mut/IDH2mut) and 1p/19q co-deletions. Previously, we reported that in IDH1mutgliomas, D-2HG, the product of IDH1 mutant enzyme produces an increase in monounsaturated fatty acid levels that are incorporated into ceramides, tilting the ...
Helena Muley   +11 more
openaire   +2 more sources

Targeting Acid Ceramidase in Acute Myeloid Leukemia

2019
Acute myeloid leukemia (AML) is a hematologic malignancy characterized by expansion of myeloid blasts. These immature cells overpopulate the blood and bone marrow leading to anemia, neutropenia and thrombocytopenia associated with increased risk of infection. AML progresses rapidly and many patients relapse after treatment.
openaire   +1 more source

AAV-mediated gene therapy of acid ceramidase deficiency

2022
Acid ceramidase deficiency is an orphan disorder caused by mutations in the ASAH1 genepresenting with a spectrum of clinical manifestations that leads to death in most cases duringearly infancy (Farber disease, FD) or at teenage (spinal muscular atrophy with progressivemyoclonic epilepsy, SMA-PME).
Denard, Jérôme   +7 more
openaire   +1 more source

Acid Ceramidase Deficiency

2009
Hubert Scharnagl   +199 more
openaire   +1 more source

Home - About - Disclaimer - Privacy